All tumors underwent routine IHC to confirm the LMS diagnosis utilizing smooth muscle markers (SMA, desmin, or H‐caldesmon) and melanoma markers (HMB45, Melan A) to exclude PEComa. The gene discussed is MLANA; the disease is neoplasm with perivascular epithelioid cell differentiation.